Global Embolic Protection Devices Market to Surpass $ 2 Bn by 2025

February 13, 2020


As per the report titled ‘Embolic Protection Devices Market Size By Product (Distal Occlusion Systems, Proximal Occlusion Systems, Distal Filters), By Application (Cardiovascular Disease, Neurovascular Disease, Peripheral Disease), By Material (Nitinol, Polyurethane), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025’ available with Market Study Report LLC, the global embolic protection devices market is projected to exceed USD 2 billion by the year 2025.
 

Rising preference for minimally invasive procedures is fueling the growth of embolic protection devices market. Technological advancements and inflowing investments in research & development, alongside increasing number of transcatheter aortic valve replacement (TAVR) treatments are the other major factors boosting the market growth. Moreover, favorable reimbursement policies in developed economies, especially for neurovascular, cardiovascular, and peripheral diseases will enhance the market outlook in the coming future. On the contrary, stringent regulations and growing availability of alternative treatment procedures may impede the market growth in the coming years.
 

Based on the product type, distal occlusion systems segment is presumed to expand with over 10% CAGR through 2025. These systems prevent embolization by a balloon occlusion of internal carotid artery distal to lesion and offer various advantages such as minimal landing zone for occlusion balloon and low crossing profile.
 

Elaborating on the application scope, embolic protection devices market from peripheral disease segment was worth 320 million in 2019 and is anticipated to see substantial growth during the analysis period, on account of rising awareness regarding minimally invasive treatment services for peripheral diseases.
 

In terms of the material used, polyurethane segment is projected to grow with 10.5% CAGR over the forecast timeline. In comparison with nitinol material, embolic protection devices with polyurethane mesh have a bigger proximal opening, allowing larger particles to pass though it. This allows in capturing the maximum number of embolic particles, thereby, increasing the demand for polyurethane based embolic protection devices.
 

Speaking of the end-use spectrum, ambulatory surgical centers segment generated approximately 31.5% revenue share in 2018 and is expected to register significant growth over the study period. Availability of varied surgical procedures in ambulatory surgical centers, coupled with favorable reimbursement policies and reduced duration of stay as compared to hospitals are driving the segmental growth.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/934011/
 

Considering the geographical landscape, Asia Pacific embolic protection devices market was worth USD 180 million in 2018 and is slated to grow momentously during 2019-2025, owing to rising prevalence of cardiovascular and neurovascular diseases in the region. Government initiatives promoting the adoption of minimally invasive procedures across emerging economies such as India and China will boost the regional growth in the years to come.
 

Major players of embolic protection devices market are Abbott Laboratories, Boston Scientific, Allium Medica, Cardinal Health, Edwards Lifesciences, Contego Medical, Medtronic, Innovative Cardiovascular Solutions, Keystone Heart, Gore Medical, Metactive Medical, and Transverse Medical.


Frequently Asked Questions (FAQ) :

Rising preference for minimally invasive procedures is fueling the growth of embolic protection devices market. Technological advancements and inflowing investments in research & development, alongside increasing number of transcatheter aortic valve replacement (TAVR) treatments are the other major factors boosting the market growth. Moreover, favorable reimbursement policies in developed economies, especially for neurovascular, cardiovascular, and peripheral diseases will enhance the market outlook in the coming future.
Distal occlusion systems segment is presumed to expand with over 10% CAGR through 2025. These systems prevent embolization by a balloon occlusion of internal carotid artery distal to lesion and offer various advantages such as minimal landing zone for occlusion balloon and low crossing profile.
Asia Pacific embolic protection devices market was worth USD 180 million in 2018 and is slated to grow momentously during 2019-2025, owing to rising prevalence of cardiovascular and neurovascular diseases in the region. Government initiatives promoting the adoption of minimally invasive procedures across emerging economies such as India and China will boost the regional growth in the years to come.
Major players of embolic protection devices market are Abbott Laboratories, Boston Scientific, Allium Medica, Cardinal Health, Edwards Lifesciences, Contego Medical, Medtronic, Innovative Cardiovascular Solutions, Keystone Heart, Gore Medical, Metactive Medical, and Transverse Medical.